Respiratory FailureREACHNCT04146753
Identifying and Understanding Risk Factors for Instability and Adverse Events Associated With Chest Physiotherapy in Ventilated Children
An observational study of Respiratory Failure, run by Great Ormond Street Hospital for Children NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
Paediatric intensive care units support the complex medical needs of children with life threatening conditions. There are 20000 admissions annually within the United Kingdom and 65% require life support through a breathing machine. Chest physiotherapy is considered part of routine care for these patients. Read more about this study
- Who is it for?
- Ages 0 to 4 years
- Conditions the study is for
- Respiratory Failure
- How many people
- 556 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 29 Jul 2020to 22 Nov 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 4 years
- All sexes
- No healthy volunteers
- Child
Study population: Children across three intensive care units at a tertiary childrens hospital
Who may be able to join
- Intubated and mechanically ventilated
- Receiving chest physiotherapy
- 0-4 years of age
- First four days of mechanical ventilation
Who cannot join
- Newborn premature babies (currently <36 weeks gestation)
- Patients requiring mechanical circulatory support
- Patients not for escalation of care or not receiving active treatment
Trial locations and contacts
1 site in 1 country.
About this study
Paediatric intensive care units support the complex medical needs of children with life threatening conditions. There are 20000 admissions annually within the United Kingdom and 65% require life support through a breathing machine. Chest physiotherapy is considered part of routine care for these patients. There is a small amount of evidence providing support for the effectiveness of chest physiotherapy however it has been associated with instability and adverse events. At present the risks and benefits of chest physiotherapy in ventilated children are unknown. It is important to identify which patients are likely to benefit most and in which situations chest physiotherapy may present a significant risk.
Aim: To identify and understand the risk factors for instability and harmful events which may occur due to chest physiotherapy in children on intensive care.
Read more
Design/Methods
Work Package 1
Phase 1 - An anonymous, electronic survey will be sent to all UK physiotherapists who work in paediatric critical care. Information will be collected about physiotherapy practice, referrals, and risk factors assessed and monitored.
Phase 2 - Interviews with 18-27 physiotherapists will take place. The findings from phase 1 will guide the questions. Phase 2 will provide a more in-depth understanding about physiotherapy decision making and management of risks.
Work Package 2
This part of the study will quantitatively assess the effects of chest physiotherapy and identify risk factors for instability. Routinely collected data from the three intensive care units at Great Ormond Street Hospital will be used. No contact with patients/families will be required, and no change to care will occur. Data from approximately 1000 patients will be collected over one year. Health related measures (e.g. oxygen levels) will be recorded before and after chest physiotherapy.
Read the detailed description
Research Questions
- What is current chest physiotherapy practice within UK paediatric intensive care units?
- How do physiotherapists make decisions regarding provision of chest physiotherapy in UK paediatric intensive care units and what other factors influence this decision making?
- What do physiotherapists perceive to be risk factors for physiological instability and adverse events and how do they manage these?
- What is the prevalence of physiological instability and adverse events associated with chest physiotherapy in ventilated children?
- What are the risk factors/characteristics of children who display instability and/or adverse events associated with chest physiotherapy?
- What is the long term impact on the child of instability and adverse events associated with chest physiotherapy?
WORK PACKAGE 1
Phase 1 A descriptive, cross sectional study investigating current chest physiotherapy practice in paediatric intensive care units.
Sample The subject group is physiotherapists working within the 28 NHS PICUs in the UK. Using information from a local benchmarking study which investigated physiotherapy staffing levels on seven UK PICUs, a total of 33 physiotherapy staff was reported, providing an average of four per site. Extrapolating this for the 28 national centres gives an approximate population size of 112 physiotherapists.
Method An electronic survey, created in Smart-survey will be used. The first page of the questionnaire will include a covering statement and a link to the more comprehensive participant information sheet. The survey includes dichotomous and multiple choice closed questions, and open questions where more detail is required. It will be self-administered and anonymous.
Key topics covered include:
- Chest physiotherapy techniques used
- Chest physiotherapy referral criteria
- Decision to treat/not treat processes
- Risk factors monitored
- Demographic information The survey will be open for eight weeks and a reminder email will be sent after four weeks. Consent will be implied if the survey is completed and returned.
Data Analysis The anonymous data will be imported into Excel and descriptive statistics will be used including frequency distributions, statistics of central tendency, and dispersion. Qualitative data from the open questions will be thematically analysed, as described by Braun and Clarke (2006).
Phase 2 A qualitative study to explore and understand the decision making processes that guide delivery of chest physiotherapy, including the perceived risk factors for physiological instability and adverse events, and risk management strategies.
Sample Nine paediatric critical care units have been pre-selected, these are representative of all 28 UK NHS PICUs. Up to three physiotherapists will be purposively sampled from each centre to ensure a heterogeneous sample in terms of agenda for change banding and years of experience. This strategy will generate a sample size of 18-27 and ensure saturation of themes.
Method Semi-structured interviews will be conducted. Eligible participants will be provided with appropriate study information and all participants asked to give written consent prior to taking part. The interviews will take place at a time and location convenient to the participant, outside of their contracted working hours. The interviews will last between 30-60 minutes. Where possible the interviews will be face to face, however Skype/telephone interviews will also be offered. A topic guide for the interviews will be developed using the data from phase 1, existing literature, and advice from the steering group. The topic guide will be piloted in the first three interviews. The pilot data will be included in the data set unless significant revisions to the topic guide are required. The interviews will be audio recorded, with permission, and transcribed verbatim. Field notes will be taken to provide context and information on non-verbal cues.
Data Analysis Thematic analysis will be used to analyse the interview transcripts, to identify, organise and report themes within the data. The themes will be presented logically and meaningfully, evidenced and illustrated with quotes as appropriate. A visual display of the findings will also be developed.
WORK PACKAGE 2 An observational (case-note review) study to assess the variability and prevalence of physiological instability and adverse events associated with chest physiotherapy, and identify risk factors that predict instability.
Sample The sampling frame will consist of patients on the three paediatric critical care units at a tertiary children's hospital (neonatal, general paediatric, cardiac).
Subject Recruitment Patients who meet the inclusion criteria will be identified from physiotherapy records on a weekly basis by the chief investigator.
Data Collection This study will involve the collection of four categories of variables: primary and secondary outcomes, risk factors/demographics, and general PICU outcomes. These are routinely monitored and recorded for all patients on the PICUs. They are retrieved from high resolution monitor data (T3) and electronic patient records (EPR). A workspace within the digital platform Aridhia will be designed collaboratively with the GOSH Digital Research, Informatics and Virtual Environments (DRIVE) team. This will provide a comprehensive and secure database to collate, store and analyse the data. The DRIVE team will downloaded the de-identified data into the workspace.
Sample Size and Planned Recruitment Rate The use of digital methods allows a larger sample than in previous experimental and retrospective studies. Retrospective data will be collected over a 12 month period. An audit of chest physiotherapy across the three PICUs was completed over one week. Twenty two patients, accounting for 77 CPT events, were identified who would meet the study inclusion criteria. Scaling this up, data collection over a 12 month period would provide an approximate sample of 1144 patients and 4000 CPT treatments. Completing the data collection over a full year will avoid the impact of seasonal bias on the sample.
Data Analysis The analysis will be completed using the R Project for Statistical Computing. Multilevel analysis will be used to investigate change in the physiological variables and allow risk modelling.
Data Synthesis The findings of both work packages will be synthesised to determine similarities and disparities between the perceived risks of physiological instability and adverse events associated with CPT and those demonstrated by the objective data. Side by side comparison for merged data analysis will be used in a summary table and through visual data representation. This will clarify the new knowledge created and areas for service improvement.
- Conditions
- Respiratory Failure
- Keywords
- Chest physiotherapy, Paediatric intensive care unit, Physiological instability, Adverse events
- Medical subject headings
- Respiratory Insufficiency
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxygenation
Work package 2 - Arterial oxygen saturations (SpO2), measured non-invasively by a finger pulse oximeter.
Measured: Change in baseline Sp02 for 30 minutes before chest physiotherapy and 30 minutes after
Secondary outcomes (3)
Heart rate
Work package 2 - Heart rate (HR) - measured by Electrocardiography.
Measured: Change in baseline HR for 30 minutes before chest physiotherapy and 30 minutes
Mean blood pressure
Work package 2 - Mean arterial blood pressure (MBP) - measured invasively by an arterial line or non-invasively by a blood pressure cuff.
Measured: Change in baseline HR and MBP for 30 minutes before chest physiotherapy and 30 minutes
Presence of Adverse Events
Work package 2
- Presence of cardiac arrhythmia (yes/no)
- Unplanned extubation (yes/no)
- Cardiorespiratory arrest (yes/no)
- Loss of venous access (yes/no)
Measured: 30 minutes after chest physiotherapy
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2019
- Study start29 Jul 2020
- Primary completion22 Nov 2021
- Study completion22 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Respiratory FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 556 participants (actual)
Sponsor and investigators
- Lead sponsor
- Great Ormond Street Hospital for Children NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Collaborators
- University College, London
- Responsible party
- Sponsor
- Investigators
- Emma Shkurka, Principal investigator, Great Ormond Street Hospital for Children NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04146753
- Sponsor's protocol ID
- 18BA19
- Acronym
- REACH
- Status last verified
- Jan 2022
- First submitted
- 9 Oct 2019
- Last updated
- 10 Jan 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jan 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Identifying and Understanding Risk Factors for Instability and Adverse Events Associated With Chest Physiotherapy in Ventilated Children
- ClinicalTrials.gov ID
- NCT04146753
- Acronym / sponsor ID
- REACH / 18BA19
- Conditions
- Respiratory Failure
- Keywords
- Chest physiotherapy, Paediatric intensive care unit, Physiological instability, Adverse events
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 556 participants (actual)
- Lead sponsor
- Great Ormond Street Hospital for Children NHS Foundation TrustUniversity, hospital or other
- Collaborators
- University College, London
- Study start
- 29 Jul 2020 (actual)
- Primary completion
- 22 Nov 2021 (actual)
- Study completion
- 22 Nov 2021 (actual)
- First posted
- 31 Oct 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Paediatric intensive care units support the complex medical needs of children with life threatening conditions. There are 20000 admissions annually within the United Kingdom and 65% require life support through a breathing machine. Chest physiotherapy is considered part of routine care for these patients. There is a small amount of evidence providing support for the effectiveness of chest physiotherapy however it has been associated with instability and adverse events. At present the risks and benefits of chest physiotherapy in ventilated children are unknown. It is important to identify which patients are likely to benefit most and in which situations chest physiotherapy may present a significant risk.
Aim: To identify and understand the risk factors for instability and harmful events which may occur due to chest physiotherapy in children on intensive care.
Design/Methods
Work Package 1
Phase 1 - An anonymous, electronic survey will be sent to all UK physiotherapists who work in paediatric critical care. Information will be collected about physiotherapy practice, referrals, and risk factors assessed and monitored.
Phase 2 - Interviews with 18-27 physiotherapists will take place. The findings from phase 1 will guide the questions. Phase 2 will provide a more in-depth understanding about physiotherapy decision making and management of risks.
Work Package 2
This part of the study will quantitatively assess the effects of chest physiotherapy and identify risk factors for instability. Routinely collected data from the three intensive care units at Great Ormond Street Hospital will be used. No contact with patients/families will be required, and no change to care will occur. Data from approximately 1000 patients will be collected over one year. Health related measures (e.g. oxygen levels) will be recorded before and after chest physiotherapy.
Detailed description
Research Questions
- What is current chest physiotherapy practice within UK paediatric intensive care units?
- How do physiotherapists make decisions regarding provision of chest physiotherapy in UK paediatric intensive care units and what other factors influence this decision making?
- What do physiotherapists perceive to be risk factors for physiological instability and adverse events and how do they manage these?
- What is the prevalence of physiological instability and adverse events associated with chest physiotherapy in ventilated children?
- What are the risk factors/characteristics of children who display instability and/or adverse events associated with chest physiotherapy?
- What is the long term impact on the child of instability and adverse events associated with chest physiotherapy?
WORK PACKAGE 1
Phase 1 A descriptive, cross sectional study investigating current chest physiotherapy practice in paediatric intensive care units.
Sample The subject group is physiotherapists working within the 28 NHS PICUs in the UK. Using information from a local benchmarking study which investigated physiotherapy staffing levels on seven UK PICUs, a total of 33 physiotherapy staff was reported, providing an average of four per site. Extrapolating this for the 28 national centres gives an approximate population size of 112 physiotherapists.
Method An electronic survey, created in Smart-survey will be used. The first page of the questionnaire will include a covering statement and a link to the more comprehensive participant information sheet. The survey includes dichotomous and multiple choice closed questions, and open questions where more detail is required. It will be self-administered and anonymous.
Key topics covered include:
- Chest physiotherapy techniques used
- Chest physiotherapy referral criteria
- Decision to treat/not treat processes
- Risk factors monitored
- Demographic information The survey will be open for eight weeks and a reminder email will be sent after four weeks. Consent will be implied if the survey is completed and returned.
Data Analysis The anonymous data will be imported into Excel and descriptive statistics will be used including frequency distributions, statistics of central tendency, and dispersion. Qualitative data from the open questions will be thematically analysed, as described by Braun and Clarke (2006).
Phase 2 A qualitative study to explore and understand the decision making processes that guide delivery of chest physiotherapy, including the perceived risk factors for physiological instability and adverse events, and risk management strategies.
Sample Nine paediatric critical care units have been pre-selected, these are representative of all 28 UK NHS PICUs. Up to three physiotherapists will be purposively sampled from each centre to ensure a heterogeneous sample in terms of agenda for change banding and years of experience. This strategy will generate a sample size of 18-27 and ensure saturation of themes.
Method Semi-structured interviews will be conducted. Eligible participants will be provided with appropriate study information and all participants asked to give written consent prior to taking part. The interviews will take place at a time and location convenient to the participant, outside of their contracted working hours. The interviews will last between 30-60 minutes. Where possible the interviews will be face to face, however Skype/telephone interviews will also be offered. A topic guide for the interviews will be developed using the data from phase 1, existing literature, and advice from the steering group. The topic guide will be piloted in the first three interviews. The pilot data will be included in the data set unless significant revisions to the topic guide are required. The interviews will be audio recorded, with permission, and transcribed verbatim. Field notes will be taken to provide context and information on non-verbal cues.
Data Analysis Thematic analysis will be used to analyse the interview transcripts, to identify, organise and report themes within the data. The themes will be presented logically and meaningfully, evidenced and illustrated with quotes as appropriate. A visual display of the findings will also be developed.
WORK PACKAGE 2 An observational (case-note review) study to assess the variability and prevalence of physiological instability and adverse events associated with chest physiotherapy, and identify risk factors that predict instability.
Sample The sampling frame will consist of patients on the three paediatric critical care units at a tertiary children's hospital (neonatal, general paediatric, cardiac).
Subject Recruitment Patients who meet the inclusion criteria will be identified from physiotherapy records on a weekly basis by the chief investigator.
Data Collection This study will involve the collection of four categories of variables: primary and secondary outcomes, risk factors/demographics, and general PICU outcomes. These are routinely monitored and recorded for all patients on the PICUs. They are retrieved from high resolution monitor data (T3) and electronic patient records (EPR). A workspace within the digital platform Aridhia will be designed collaboratively with the GOSH Digital Research, Informatics and Virtual Environments (DRIVE) team. This will provide a comprehensive and secure database to collate, store and analyse the data. The DRIVE team will downloaded the de-identified data into the workspace.
Sample Size and Planned Recruitment Rate The use of digital methods allows a larger sample than in previous experimental and retrospective studies. Retrospective data will be collected over a 12 month period. An audit of chest physiotherapy across the three PICUs was completed over one week. Twenty two patients, accounting for 77 CPT events, were identified who would meet the study inclusion criteria. Scaling this up, data collection over a 12 month period would provide an approximate sample of 1144 patients and 4000 CPT treatments. Completing the data collection over a full year will avoid the impact of seasonal bias on the sample.
Data Analysis The analysis will be completed using the R Project for Statistical Computing. Multilevel analysis will be used to investigate change in the physiological variables and allow risk modelling.
Data Synthesis The findings of both work packages will be synthesised to determine similarities and disparities between the perceived risks of physiological instability and adverse events associated with CPT and those demonstrated by the objective data. Side by side comparison for merged data analysis will be used in a summary table and through visual data representation. This will clarify the new knowledge created and areas for service improvement.
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Ages
- 0 to 4 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Children across three intensive care units at a tertiary childrens hospital
Key inclusion criteria (4 listed)
- Intubated and mechanically ventilated
- Receiving chest physiotherapy
- 0-4 years of age
- First four days of mechanical ventilation
Key exclusion criteria (3 listed)
- Newborn premature babies (currently <36 weeks gestation)
- Patients requiring mechanical circulatory support
- Patients not for escalation of care or not receiving active treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Oxygenation
Time frame: Change in baseline Sp02 for 30 minutes before chest physiotherapy and 30 minutes after
Work package 2 - Arterial oxygen saturations (SpO2), measured non-invasively by a finger pulse oximeter.
3 secondary outcomes
Heart rate
Time frame: Change in baseline HR for 30 minutes before chest physiotherapy and 30 minutes
Mean blood pressure
Time frame: Change in baseline HR and MBP for 30 minutes before chest physiotherapy and 30 minutes
Presence of Adverse Events
Time frame: 30 minutes after chest physiotherapy
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jan 2022.
Related trials for Respiratory Failure
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Regional Lung Ventilation During Prone Position in in Intubated Children
Pediatric Acute Respiratory Failure
Not yet recruiting
Smartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy Adults
Respiratory Sinus Arrhythmia, Heart Rate Variability
Not yet recruiting
Mechanical Ventilator Adjustments and Patient Dyspnea
Respiratory Failure, Dyspnea During Mechanical Ventilation
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Emma Shkurka principal investigator
Great Ormond Street Hospital for Children NHS Foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Respiratory Failure, run by Great Ormond Street Hospital for Children NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxygenation (time frame: Change in baseline Sp02 for 30 minutes before chest physiotherapy and 30 minutes after). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2022.